文献速递其他结缔组织病

组蛋白修饰介导系统性硬化症单核细胞失调,提示表观遗传靶向治疗潜力

Histone modifications underlie monocyte dysregulation in patients with systemic sclerosis, underlining the treatment potential of epigenetic targeting.
PubMed 文献 · Ann Rheum Dis · 2019-02-06

本研究对9例健康对照和14例系统性硬化症(SSc)患者的单核细胞进行H3K4me3和H3K27ac的ChIP-seq及RNA测序,发现SSc单核细胞存在1046和534个异常组蛋白修饰位点,381个基因表达与转录起始位点附近的染色质标记水平直接显著相关,这些基因富集于免疫、干扰素和抗病毒通路,且启动子区有IRF和STAT转录因子结合位点。IFNα诱导STAT1和STAT2结合其中两个基因的启动子,而溴结构域BET家族抑制剂JQ1抑制其表达。结论提示调节这些可逆组蛋白修饰的酶可能成为恢复单核细胞稳态、治疗甚至预防SSc的靶点。

要点

  • SSc单核细胞存在H3K4me3和H3K27ac异常修饰,与干扰素签名相关。
  • 381个基因表达与转录起始位点附近组蛋白修饰水平直接显著相关。
  • BET抑制剂JQ1抑制IFN响应基因表达,提示表观遗传靶向治疗潜力。

核心结论

  • SSc单核细胞具有与干扰素签名相关的异常染色质标记,调节这些可逆标记的酶可能为治疗或预防SSc提供靶点。

研究设计与样本

  • 对9例健康对照和14例SSc患者的单核细胞进行H3K4me3和H3K27ac的ChIP-seq,并行RNA测序,用ChIP-qPCR验证溴结构域蛋白、H3K27ac和STAT对IFN响应基因表达的作用。

主要发现

  • SSc单核细胞中分别有1046和534个基因组位点显示异常H3K4me3和H3K27ac标记。
  • 381个基因的表达与转录起始位点附近染色质标记水平直接且显著成正比。
  • 与异常组蛋白修饰相关的基因富集于免疫、IFN和抗病毒通路,启动子区有IRF和STAT转录因子反复出现的结合位点。
  • IFNα诱导STAT1和STAT2结合其中两个基因的启动子,BET家族抑制剂JQ1阻断乙酰化阅读器后抑制其表达。

临床怎么用

  • 监测SSc单核细胞组蛋白修饰及IFN响应基因表达可能有助于评估疾病活动。
  • 靶向组蛋白修饰酶或BET蛋白可能成为恢复单核细胞稳态的治疗策略。

局限性

  • 样本量较小(9例对照和14例SSc患者),需更大样本验证。
  • 研究仅观察相关性,未证明组蛋白修饰改变与SSc发病的因果关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: Systemic sclerosis (SSc) is a severe autoimmune disease, in which the pathogenesis is dependent on both genetic and epigenetic factors. Altered gene expression in SSc monocytes, particularly of interferon (IFN)-responsive genes, suggests their involvement in SSc development. We investigated the correlation between epigenetic histone marks and gene expression in SSc monocytes. METHODS: Chromatin immunoprecipitation followed by sequencing (ChIPseq) for histone marks H3K4me3 and H3K27ac was performed on monocytes of nine healthy controls and 14 patients with SSc. RNA sequencing was performed in parallel to identify aberrantly expressed genes and their correlation with the levels of H3K4me3 and H3K27ac located nearby their transcription start sites. ChIP-qPCR assays were used to verify the role of bromodomain proteins, H3K27ac and STATs on IFN-responsive gene expression. RESULTS: 1046 and 534 genomic loci showed aberrant H3K4me3 and H3K27ac marks, respectively, in SSc monocytes. The expression of 381 genes was directly and significantly proportional to the levels of such chromatin marks present near their transcription start site. Genes correlated to altered histone marks were enriched for immune, IFN and antiviral pathways and presented with recurrent binding sites for IRF and STAT transcription factors at their promoters. IFNα induced the binding of STAT1 and STAT2 at the promoter of two of these genes, while blocking acetylation readers using the bromodomain BET family inhibitor JQ1 suppressed their expression. CONCLUSION: SSc monocytes have altered chromatin marks correlating with their IFN signature. Enzymes modulating these reversible marks may provide interesting therapeutic targets to restore monocyte homeostasis to treat or even prevent SSc.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. van der Kroef M, Castellucci M, Mokry M, et al. Histone modifications underlie monocyte dysregulation in patients with systemic sclerosis, underlining the treatment potential of epigenetic targeting. Ann Rheum Dis. 2019. PMID: 30793699. doi:10.1136/annrheumdis-2018-214295

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。